International Stemcell
Business Services · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
5950 Priestly Dr, Carlsbad, California, ...Phone Number
(760) 940-6383Revenue
$7.8 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
2
1
1
About International Stemcell
International Stem Cell Corporation (ISCO) is focused on the therapeutic applications of human parthenogenetic stem cells (hpSCs) and the development and commercialization of cell-based research and cosmetic products. ISCO's core technology, parthenogenesis, results in the creation of pluripotent human stem cells from unfertilized oocytes (eggs). hpSCs avoid ethical issues associated with the use or destruction of viable human embryos. ISCO scientists have created the first parthenogenetic, homozygous stem cell line that can be a source of therapeutic cells for hundreds of millions of individuals of differing genders, ages and racial background with minimal immune rejection after transplantation. hpSCs offer the potential to create the first true stem cell bank, UniStemCell. ISCO also produces and markets specialized cells and growth media for therapeutic research worldwide, through its subsidiary Lifeline Cell Technology (www.lifelinecelltech.com), and stem cell-based skin care producRead more
International Stemcell Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is International Stemcell your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when International Stemcell launches new products
Check out if International Stemcell is spiking on competitors!
Check if International Stemcell has recently received funding, and reach out quickly before it becomes old news!
International Stemcell, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on International Stemcell recently announced quarterly report
Click to see if International Stemcell had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at International Stemcell
Funding: Get notified immidiatlly once International Stemcell has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to International Stemcell
Compare insights from companies similar to International Stemcell, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
International Stemcell is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
International Stemcell is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about International Stemcell.
International Stemcell financials insights
Gather financial insights about International Stemcell, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Debt
$350K
2021
Debt
$474K
International Stemcell Tech Stack
A closer look at the technologies used by International Stemcell
Most Recent Scoops
Funding
International Stemcell has received an SBA PPP loan in the amount of $474,147 from Endeavor Bank resulting in the retention of 35 jobs.
Funding
International Stemcell has received an SBA PPP loan for $350,000-1 million from Wells Fargo Bank.
Funding
International Stem Cell Corporation has received an SBA PPP loan for $350,000-1 million from Wells Fargo Bank, National Association.
Funding
International Stemcell News & Media
International Stem Cell Corporation Announces Operating Results for the Quarter Ended March 31, 2019
CARLSBAD, Calif., May 17, 2019 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO) (www.internationalstemcell.com) ("ISCO" or "the Company"), a California-based clinical stage biotechnology company developing novel stem cell-based therapies and biomedical products, today provided a business update announcing operating results for the three months ended March 31, 2019.International Stem Cell Corporation is Valued at $43 Million Market Value by Edison Investment Research
CARLSBAD, Calif., May 08, 2019 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO) ("ISCO" or "the Company"), a California-based clinical stage biotechnology company developing novel stem cell-based therapies and biomedical products, announced today that it has been valued at $43 million, up from $42 million in December 2018, by Edison Investment Research ("Edison")*, a world-renowned investment intelligence firm with more than one hundred analysts, investment experts, and roadsInternational Stem Cell Corporation Completes Enrollment and Dosing in its Parkinson's Disease Clinical Trial
CARLSBAD, Calif., April 29, 2019 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQX: ISCO) (www.internationalstemcell.com) ("ISCO" or "the Company"), a California-based clinical stage biotechnology company developing stem cell-based therapies and biomedical products, announced today the completion of subject enrollment in its phase 1 clinical trial of ISC-hpNSC® for the treatment of Parkinson’s disease. The fourth subject of the third cohort, who was the twelfth and final subject ofInternational Stem Cell Corporation Announces 2018 Fourth Quarter and Year-End Results
CARLSBAD, Calif., April 15, 2019 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQX: ISCO) (www.internationalstemcell.com) ("ISCO" or "the Company"), a California-based clinical stage biotechnology company developing novel stem cell-based therapies and biomedical products, today announced fourth quarter and year-end financial results for the period ending on December 31, 2018 and provided a business update.
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding International Stemcell
Sign Up For FreeTo access detailed company insights
International Stem Cell Corporation (ISCO) is focused on the therapeutic applications of human parthenogenetic stem cells (hpSCs) and the development and commercialization of cell-based research and cosmetic products. ISCO's core technology, parthenogenesis, results in the creation of pluripotent human stem cells from unfertilized oocytes (eggs). h... Read More
